Gui-Zhe Yao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gui-Zhe Yao has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Hai-Long Yu
College of Veterinary Medicine, Qingdao Agricultural University
1 shared publicationHai-Tao Wang
College of Life Sciences, Changchun Sci-Tech University
1 shared publicationHong-Bo Ni
College of Veterinary Medicine, Qingdao Agricultural University
1 shared publication- Hongchao Zhou
College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, China
1 shared publication Kai-Meng Shang
College of Veterinary Medicine, Qingdao Agricultural University
1 shared publicationLi Guo
Animal Science and Technology College, Jilin Agricultural Science and Technology University
1 shared publication
Latest Publications
- Open Access
- 30 October 2026
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1995610
Characteristics of Klebsiella spp. from sheep flocks in northern China
Background: Klebsiella spp. are Gram-negative opportunistic pathogens that affect both humans and animals. However, data on their antimicrobial resistance and virulence characteristics in sheep, particularly in China, remain limited. Methods: In 2024, 421 sheep fecal samples were collected from six regions in northern China. Klebsiella spp. were isolated and identified, followed by antimicrobial susceptibility testing and PCR screening for virulence-associated genes. The pathogenic potential of selected isolates was evaluated using the Galleria mellonella infection model. Whole-genome sequencing was performed on 26 selected isolates to characterize their antimicrobial resistance and virulence determinants. Results: Klebsiella spp. were isolated from 120 samples, corresponding to an overall detection rate of 28.5%, including 85 Klebsiella pneumoniae isolates (70.8%, 85/120). All isolates were resistant to sulfamethoxazole, with high resistance to tetracycline (76.7%), florfenicol (42.5%), and ciprofloxacin (41.7%). Resistance to tigecycline (10.0%) and polymyxin B (5.8%) was also observed at lower levels. Overall, 64.2% of the isolates exhibited multidrug resistance. PCR screening revealed virulence-associated genes, including iucA (10.8%), rmpA (8.3%), peg -344 (0.8%), and iroB (3.3%). Based on their virulence-associated gene profiles, 14 isolates were selected for further analysis, of which 11 exhibited high pathogenic potential in the Galleria mellonella infection model. Whole-genome sequencing revealed diverse virulence and antimicrobial resistance determinants. No plasmid-mediated resistance determinants related to polymyxin B (e.g., mcr-like genes) or recognized tigecycline resistance determinants were identified in the genomes. In the isolates analyzed in this study, mutations in lipid A modification and regulatory genes, including arnT and pmrA / pmrB , may have contributed to polymyxin B resistance, while mutations in efflux pump-associated genes, including oqxA / oqxB, acrA , and acrR , may have contributed to tigecycline resistance. Conclusion: Multidrug resistance and pathogenic potential coexist among Klebsiella spp. isolated from healthy sheep in northern China. These findings suggest that sheep-associated Klebsiella may serve as reservoirs of clinically relevant antimicrobial resistance and virulence determinants, highlighting the need for continued surveillance and prudent antimicrobial use in livestock.
- 30 October 2026
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1995610
Open AccessCharacteristics of Klebsiella spp. from sheep flocks in northern China
Background: Klebsiella spp. are Gram-negative opportunistic pathogens that affect both humans and animals. However, data on their antimicrobial resistance and virulence characteristics in sheep, particularly in China, remain limited. Methods: In 2024, 421 sheep fecal samples were collected from six regions in northern China. Klebsiella spp. were isolated and identified, followed by antimicrobial susceptibility testing and PCR screening for virulence-associated genes. The pathogenic potential of selected isolates was evaluated using the Galleria mellonella infection model. Whole-genome sequencing was performed on 26 selected isolates to characterize their antimicrobial resistance and virulence determinants. Results: Klebsiella spp. were isolated from 120 samples, corresponding to an overall detection rate of 28.5%, including 85 Klebsiella pneumoniae isolates (70.8%, 85/120). All isolates were resistant to sulfamethoxazole, with high resistance to tetracycline (76.7%), florfenicol (42.5%), and ciprofloxacin (41.7%). Resistance to tigecycline (10.0%) and polymyxin B (5.8%) was also observed at lower levels. Overall, 64.2% of the isolates exhibited multidrug resistance. PCR screening revealed virulence-associated genes, including iucA (10.8%), rmpA (8.3%), peg -344 (0.8%), and iroB (3.3%). Based on their virulence-associated gene profiles, 14 isolates were selected for further analysis, of which 11 exhibited high pathogenic potential in the Galleria mellonella infection model. Whole-genome sequencing revealed diverse virulence and antimicrobial resistance determinants. No plasmid-mediated resistance determinants related to polymyxin B (e.g., mcr-like genes) or recognized tigecycline resistance determinants were identified in the genomes. In the isolates analyzed in this study, mutations in lipid A modification and regulatory genes, including arnT and pmrA / pmrB , may have contributed to polymyxin B resistance, while mutations in efflux pump-associated genes, including oqxA / oqxB, acrA , and acrR , may have contributed to tigecycline resistance. Conclusion: Multidrug resistance and pathogenic potential coexist among Klebsiella spp. isolated from healthy sheep in northern China. These findings suggest that sheep-associated Klebsiella may serve as reservoirs of clinically relevant antimicrobial resistance and virulence determinants, highlighting the need for continued surveillance and prudent antimicrobial use in livestock.
- Open Access
- 10 December 2010
- Published by Springer Nature in Virology Journal
- Vol. 7 (1) , 366
Production and purification of VP2 protein of porcine parvovirus expressed in an insect-baculovirus cell system
The porcine parvovirus (PPV) VP2 protein was expressed in an insect-baculovirus cell system and was purified using Ni-NTA affinity column chromatography. The recombinant 6-His-tagged VP2 protein with molecular mass (Mr) of about 64 kDa was detected by anti-his antibody and anti-PPV serum. Electron microscopy showed that the purified VP2 protein assembled into spherical particles with diameters ranging from 20 to 22 nm. The expressed VP2 was antigenically similar to the native capsid protein according to HA and a Western blotting assay performed with polyclonal antibodies collected from an outbreak of PPV in one farm. This study provides a foundation for the application of VP2 protein in the clinical diagnosis of PPV or in the vaccination against PPV in the future.
- 10 December 2010
- Published by Springer Nature in Virology Journal
- Vol. 7 (1) , 366
Open AccessProduction and purification of VP2 protein of porcine parvovirus expressed in an insect-baculovirus cell system
The porcine parvovirus (PPV) VP2 protein was expressed in an insect-baculovirus cell system and was purified using Ni-NTA affinity column chromatography. The recombinant 6-His-tagged VP2 protein with molecular mass (Mr) of about 64 kDa was detected by anti-his antibody and anti-PPV serum. Electron microscopy showed that the purified VP2 protein assembled into spherical particles with diameters ranging from 20 to 22 nm. The expressed VP2 was antigenically similar to the native capsid protein according to HA and a Western blotting assay performed with polyclonal antibodies collected from an outbreak of PPV in one farm. This study provides a foundation for the application of VP2 protein in the clinical diagnosis of PPV or in the vaccination against PPV in the future.